New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has set retail prices for 23 drug formulations, including those used for the treatment of blood pressure and other heart complications, seizures, fever, diabetes and bacterial infections. Few drugs will experience a price increase while most drugs will experience a price decrease.
Manufacturers of these drug formulations will now have to follow new retail prices recommended by the drug price regulator.
The authority set the retail price of these drug formulations based on the 96th meeting of the authority held in the last week of March.
The retail price of the drug formulation is set by the manufacturers based on the retail price determined by the government plus local taxes.
Some of these drug formulations include telmisartan cilnidipine and chlorthalidone tablets from Unison Pharmaceuticals, diphenhydramine tablets from Dr Reddy Laboratories, cefixime, cloxacillin and lactic acid tablets from Akums Drugs & Pharmaceuticals, Mascot Health and Zydus Healthcare paracetamol and mefenamic acid and levetiracetam tablets respectively.
The highest price was recommended for Ceftriaxone and Tazobactam for Injection 1125 mg per vial at ₹167.87 manufactured by Prosperity Six Pharmaceuticals and Torrent Pharmaceuticals. This injection is an antibiotic used to treat several bacterial infections of the urinary tract, blood, bones and joints, heart, brain, chest, ears, skin or soft tissues.
The NPPA notification that was reviewed by Mint stated that the manufacturer of these drug formulations must set the retail price in accordance with the Drugs and Price Control Order 2013. In addition, the manufacturer must issue a price list to the NPPA through the Integrated Pharmaceutical Database Management System (IPDMS) and submit a copy to the state drug controller and dealers.
In accordance with the DPCO 2013, every retailer and reseller must display the price list as provided by the manufacturer where they do business in such a way as to be easily accessible to anyone wishing to consult it.
Last month, the drug price regulator announced that the prices of 800 drugs and essential drugs had risen by 10.7%. Medicines that are included in the National Essential Medicines List (NELM) such as antibiotics, anti-inflammatories, ear, nose and throat medicines, antiseptics, painkillers, gastrointestinal medicines and antifungal drugs, among others, will see a sharp increase in their prices. .
Email queries to the NPPA were not immediate until the time of this story’s publication.